Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01960322 · ClinicalTrials.gov registry record · Phase 1
Improving Medication-taking After Liver Transplant
A Phase 1 study of Nonadherence and Tacrolimus, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
- 3
- Study locations
NCT01960322: Completed Phase 1 study of Nonadherence and Tacrolimus, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01960322 is a Phase 1 study of Nonadherence and Tacrolimus that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01960322, a Phase 1 study of Nonadherence and Tacrolimus, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
- 3
- Study locations
Study Summary
The specific aim is to pilot-test our developed intervention manual's ability to improve patients' adherence to medications and medical outcomes (rejection rate, liver enzyme levels) in participating centers.
Primary Outcome
Change in Adherence at one year compared to at baseline measured via the Standard Deviation of Tacrolimus levels obtained
Conditions Studied
Interventions
- BEHAVIORAL Telemetric
Study Locations (3)
California
- UCLA Mattell Children's Hospital - Los Angeles
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
What the finished NCT01960322 record still lists
NCT01960322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Nonadherence appearing as the primary indexed condition, and to 1 intervention - of which Telemetric is the first listed.
NCT01960322 reports a single indexed study location in California, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01960322 about?
NCT01960322 is a clinical study titled "Improving Medication-taking After Liver Transplant". The specific aim is to pilot-test our developed intervention manual's ability to improve patients' adherence to medications and medical outcomes (rejection rate, liver enzyme levels) in participating centers.
What is the current status of trial NCT01960322?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2014-08. Estimated completion is 2016-05.
What conditions does trial NCT01960322 study?
This clinical trial studies the following conditions: Nonadherence, Tacrolimus, Pediatric Liver Transplant Recipients.
What interventions are being tested in trial NCT01960322?
The interventions under investigation include: Telemetric (BEHAVIORAL).
Who is sponsoring clinical trial NCT01960322?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01960322 being conducted?
This trial has 3 study locations across California, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01960322's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia